The astrocyte in multiple sclerosis revisited (Q28283441)

https://api.crossref.org/works/10.1002%2FGLIA.22443

The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

An alpha-syntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

The molecular basis of water transport in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Interferon-beta therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Molecular diversity of astrocytes with implications for neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Chondroitinase ABC promotes functional recovery after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Reactive nitrogen intermediates in human neuropathology: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Transgenic models for cytokine-induced neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Sequence of tissue responses in the early stages of experimental allergic encephalomyelitis (EAE): immunohistochemical, light microscopic, and ultrastructural observations in the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Alterations of striatal neurotransmitter release in aquaporin-4 deficient mice: An in vivo microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Overcoming remyelination failure in multiple sclerosis and other myelin disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Reactive astrocytes protect tissue and preserve function after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Overcoming inhibition in the damaged spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Neurological autoimmunity targeting aquaporin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Oversulfated chondroitin sulfate plays critical roles in the neuronal migration in the cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Involvement of brain-derived neurotrophic factor (BDNF) in MP4-induced autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

The glial nature of embryonic and adult neural stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Microglial cells are a component of the perivascular glia limitans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Multiple sclerosis: a role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Central nervous system remyelination: studies in chronically damaged tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Deletion of astrocyte connexins 43 and 30 leads to a dysmyelinating phenotype and hippocampal CA1 vacuolation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Permissive and non-permissive reactive astrocytes: immunofluorescence study with antibodies to the glial hyaluronate-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Essential protective roles of reactive astrocytes in traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Astrocytes in multiple sclerosis: a product of their environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

The role of SVZ-derived neural precursors in demyelinating diseases: from animal models to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Syntrophin-dependent expression and localization of Aquaporin-4 water channel protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Effects of agrin on the expression and distribution of the water channel protein aquaporin-4 and volume regulation in cultured astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Molecular interactions of neural chondroitin sulfate proteoglycans in the brain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Gap junctions couple astrocytes and oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Perivascular spaces and the two steps to neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Multiple sclerosis. Pathology of recurrent lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Diffusion barriers evoked in the rat cortex by reactive astrogliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

The bright side of the glial scar in CNS repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Disruption of astrocyte STAT3 signaling decreases mitochondrial function and increases oxidative stress in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Regeneration beyond the glial scar

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Chondroitin sulfates are required for fibroblast growth factor-2-dependent proliferation and maintenance in neural stem cells and for epidermal growth factor-dependent migration of their progeny

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Chondroitin sulfate glycosaminoglycans control proliferation, radial glia cell differentiation and neurogenesis in neural stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Astrocytes: biology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Molecular dissection of reactive astrogliosis and glial scar formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Three distinct roles of aquaporin-4 in brain function revealed by knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Astrocytes--friends or foes in multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

The spectrum of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Neuromyelitis optica: new findings on pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Loss of astrocyte polarity marks blood-brain barrier impairment during experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Prospects of repair in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Contrasting potential of nitric oxide and peroxynitrite to mediate oligodendrocyte injury in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

P2X7 Receptor Blockade Prevents ATP Excitotoxicity in Oligodendrocytes and Ameliorates Experimental Autoimmune Encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

Membrane specialisations between demyelinated axons and astroglia in chronic EAE lesions and multiple sclerosis plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

The adhesion molecule and cytokine profile of multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

7 January 2021

Evidence for the production of peroxynitrite in inflammatory CNS demyelination

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

7 January 2021

Distinct roles for matrix metalloproteinase-2 and alpha4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

7 January 2021

The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

7 January 2021

Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

7 January 2021

Glutamate excitotoxicity in a model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

7 January 2021

BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

7 January 2021

Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22443

7 January 2021

Identifiers

DOI

10.1002/GLIA.22443

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

23322421

1 reference

Consolidated OpenCitations Corpus – April 2017